3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
20
Prostatic Neoplasms
7
Thyroid Nodule
4
Liver Neoplasms
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Sarcopenia
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Mouth Neoplasms
3
Liver Cirrhosis
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Ovarian Cysts
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hypersensitivity
2
Head and Neck Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Thrombosis
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Interventions
Temozolomide
264
Radiotherapy
119
Bevacizumab
105
Magnetic Resonance Spectroscopy
59
Radiation
47
pembrolizumab
30
Irinotecan
28
Surgical Procedures, Operative
23
Lomustine
21
Specimen Handling
19
Nivolumab
19
Radiosurgery
18
Carmustine
18
Aminolevulinic Acid
16
Erlotinib Hydrochloride
15
Drug Therapy
15
Blood Specimen Collection
14
Radiotherapy, Intensity-Modulated
13
O(6)-benzylguanine
13
Chemotherapy, Adjuvant
13
Carboplatin
13
Filgrastim
11
Cyclophosphamide
11
sargramostim
10
poly ICLC
10
atezolizumab
10
Thalidomide
10
Etoposide
10
Ipilimumab
9
Everolimus
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Glioblastoma
×
Ultrasonography
×
Clear all
NCT05062772
2024-11-15
BraTioUS-DB
Hospital del Rio Hortega
Completed
150 enrolled